Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q4 2016 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling. The question asks: does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company ALREADY SUPPLIES OR SERVES, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort? We need to look at the transcript. The company is Apollo Commercial Real Estate Finance (ARI), a commercial real estate finance company. They originate loans, invest in CMBS, etc. Their counterparties are borrowers, real estate developers, etc. The question is about whether management's forward account is about counterparties' own growth trajectories. In the transcript, management discusses their investment activity, portfolio growth, new investments, etc. They talk about their own origination platform, repeat borrowers, etc. They mention that they originated 83% of loans, 60% with repeat borrowers. They talk about their pipeline. They mention that 2017 is a peak year for commercial real estate loan maturities, and there is dry powder for private equity funds. But that is more about market conditions. They also mention specific loans: two condominium loans repaid, etc. They talk about their portfolio composition. They mention that they have a pipeline and are optimistic. But do they narrate what their counterparties (borrowers) are doing in terms of scaling? They mention that they have repeat borrowers, but they don't describe those borrowers' own expansion plans as the driver of ARI's future volume. They talk about their own ability to find investments, their platform, their leverage, etc. The question specifically asks: "does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company ALREADY SUPPLIES OR SERVES?" In this case, the company supplies capital (loans) to borrowers.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.